Fig. 1From: First preclinical evaluation of [225Ac]Ac-DOTA-JR11 and comparison with [177Lu]Lu-DOTA-JR11, alpha versus beta radionuclide therapy of NETsIC50 curves of natLa-DOTA-JR11, natLu-DOTA-JR11 and DOTA-JR11Back to article page